FindTrial
Sign In

Application of intermittent abdominal aorta occlusion in the treatment of placenta increta to improve uterine retention rate

Application of intermittent abdominal aorta occlusion in the treatment of placenta increta to improve uterine retention

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000037502
Enrollment
Unknown
Registered
2020-08-28
Start date
2020-10-01
Completion date
Unknown
Last updated
2020-10-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

placenta increta

Interventions

Experimental group:prophylactic abdominal aorta balloon occlusion before cesarean section
control group:conditional management

Sponsors

The International Peace Maternity and Children health hospital ,School of Medicine, Shanghai Jiao Tong University
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. pernicious placenta previa; 2. placenta accreta diagnosed by ultrasound or MRI; 3. singleton; 4. gestational age >=28 weeks; 5. agree to join this study.

Exclusion criteria

Exclusion criteria: twin pregnancy.

Design outcomes

Primary

MeasureTime frame
RBC transfusion;Hysterectomy;—

Secondary

MeasureTime frame
estimated blood loss;—

Countries

China

Contacts

Public ContactDandan Zhang

The International Peace Maternity and Children health hospital ,School of Medicine, Shanghai Jiao Tong University

dannazhang@outlook.com+86 18017310226

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026